Biomedical subjects
Publications and source records attributed to J M Waxman.
This article will explore three of the most viable approaches to structuring antitrust arrangements: (1) arrangements sharing substantial financial risk; (2) arrangements that will achieve substantial clinical integration in their operations; and (3) participation in a "messenger model" physician (or multiprovider) network.
Explore the source record for details and available documents.
Physician group practices increasingly are negotiating practice management agreements with management service organizations (MSOs). Understanding the issues surrounding the creation and implementation of practice management agreements is critical to maintaining a successful MSO-group practice relationship. The scope of the management commitment must be established and the agreement must provide sufficient flexibility to allow the physicians and MSO to mutually benefit from market-place changes.
Explore the source record for details and available documents.
Corporate directors and their consultants must make decisions in an uncertain and changing health care environment. The losses each may face as a result of an incomplete analysis of the true value of the entities involved in mergers or acquisitions may extend beyond the failure of the transaction to the creation of personal liability as well. Accordingly, objective, careful, detailed, and fair decision-making based upon adequate information is more critical than ever for directors if they are to be able to take advantage of the business judgment rule, and also for consultants to avoid their own liability when transactions fail to deliver the values they have estimated.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The primary purpose of CLIA and the Regulations is to strengthen federal oversight of clinical laboratories to ensure that test results are accurate and reliable. The new law and the Regulations create a national unified certification and enforcement system that affects virtually every laboratory in the country. Thus, all laboratories and health care providers with laboratory components that may be affected should carefully review the Regulations and prepare to comply with them well in advance of their September 1, 1992 implementation date.
Whether any or all of these effects actually occur is presently a matter of conjecture. Over the long term, however, it is likely that RBRVS will lead to new opportunities to structure relationships between hospitals and physicians. In practical effect, DRG payments to hospitals, coupled with RBRVS fee schedules, are designed to promote patient care in outpatient settings. This means there will be new opportunities for joint ventures and practice/management arrangements between hospitals and physicians. As these new arrangements come to fruition, both hospitals and physicians must be aware of the financial implications of the new RBRVS codes.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The new regulations governing physician incentives in managed care organizations are out, and while they might prove to be another pit of paperwork, they might also make managed care easier to swallow for consumers.